{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:44:43Z","timestamp":1780073083964,"version":"3.54.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40857"],"award-info":[{"award-number":["2021JJ40857"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901306"],"award-info":[{"award-number":["81901306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Late-onset multiple acyl-CoA dehydrogenase deficiency (LO-MADD) describes a curable autosomal recessive genetic disease caused by <jats:italic>ETFDH<\/jats:italic> mutations that result in defects in ETF-ubiquinone oxidoreductase. Almost all patients are responsive to riboflavin. This study describes the clinical presentations and genetic characteristics of five LO-MADD patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> From 2018 to 2021, we collected clinical and genetic data on five patients diagnosed with LO-MADD at our hospital and retrospectively analyzed their clinical characteristics, laboratory examination, electromyography, muscle biopsy, genetic analysis, and outcome data.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> This study included three males and two females with mean onset age of 37.8 years. Fluctuating exercise intolerance was the most common presentation. Serum creatine kinase (CK) levels were significantly elevated in all patients, and plasma acylcarnitine profiles revealed an increase in long-chain acylcarnitine species in three cases. The urinary organic acid study revealed a high level of hydroxyglutaric acid in all patients. Electrophysiology demonstrated myogenic impairment. Muscle biopsies revealed lipid storage myopathy. Molecular analysis identified nine mutations (three novels and six reported) in <jats:italic>ETFDH<\/jats:italic>. Exercise intolerance and muscle weakness were dramatically improved in all patients treated with riboflavin (100 mg) daily following diagnosis.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> LO-MADD is caused by <jats:italic>ETFDH<\/jats:italic> variants and responds well to riboflavin. Three novel <jats:italic>ETFDH<\/jats:italic> pathogenic variants were identified, expanding their spectrum in the Chinese population and facilitating future interpretation and analysis of <jats:italic>ETFDH<\/jats:italic> mutations.<\/jats:p>","DOI":"10.3389\/fneur.2021.747360","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T05:06:57Z","timestamp":1636348017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Presentations and Genetic Characteristics of Late-Onset MADD Due to ETFDH Mutations in Five Patients: A Case Series"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhenchu","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s1096-7192(02)00138-5","article-title":"Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene","volume":"77","author":"Goodman","year":"2002","journal-title":"Mol Genet Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymgme.2006.01.009","article-title":"Electron transfer flavoprotein deficiency: functional and molecular aspects","volume":"88","author":"Schiff","year":"2006","journal-title":"Mol Genet Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.bbabio.2010.10.007","article-title":"The electron transfer flavoprotein: ubiquinone oxidoreductases","volume":"1797","author":"Watmough","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/cells8020187","article-title":"Neutral lipid storage diseases as cellular model to study lipid droplet function","volume":"8","author":"Missaglia","year":"2019","journal-title":"Cells."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain."},{"key":"B6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2008.01.002","article-title":"Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2","volume":"94","author":"Yotsumoto","year":"2008","journal-title":"Mol Genet Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1073\/pnas.82.13.4517","article-title":"Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts","volume":"82","author":"Frerman","year":"1985","journal-title":"Proc Natl Acad Sci USA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.10226","article-title":"Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency","volume":"22","author":"Olsen","year":"2003","journal-title":"Hum Mutat."},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fped.2020.00118","article-title":"A synonymous variant c","volume":"8","author":"Hu","year":"2020","journal-title":"Front Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nmd.2021.01.006","article-title":"A systematic review of late-onset and very-late-onset multiple acyl-coenzyme A dehydrogenase deficiency: cohort analysis and patient report from Taiwan","volume":"31","author":"Kuo","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nmd.2006.01.001","article-title":"So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager","volume":"16","author":"Beresford","year":"2006","journal-title":"Neuromuscul Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1756286419843359","DOI":"10.1177\/1756286419843359","article-title":"Metabolic lipid muscle disorders: biomarkers and treatment","volume":"12","author":"Angelini","year":"2019","journal-title":"Ther Adv Neurol Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00415-020-09729-z","article-title":"Multiple acyl-COA dehydrogenase deficiency in elderly carriers","volume":"267","author":"Macchione","year":"2020","journal-title":"J Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10545-013-9671-6","article-title":"Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"37","author":"Xi","year":"2014","journal-title":"J Inherit Metab Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/jhg.2014.10","article-title":"Riboflavin-responsive multiple Acyl-CoA dehydrogenation deficiency in 13 cases, and a literature review in mainland Chinese patients","volume":"59","author":"Zhu","year":"2014","journal-title":"J Hum Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00109-011-0725-7","article-title":"Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c","volume":"89","author":"Wang","year":"2011","journal-title":"J Mol Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1093\/hmg\/ddt232","article-title":"Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency","volume":"22","author":"Cornelius","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/0366-6999.173438","article-title":"A historical cohort study on the efficacy of glucocorticoids and riboflavin among patients with late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"129","author":"Liu","year":"2016","journal-title":"Chin Med J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ymgme.2013.04.007","article-title":"Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation","volume":"109","author":"Wen","year":"2013","journal-title":"Mol Genet Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/jnnp.2009.176404","article-title":"Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations","volume":"81","author":"Wen","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nmd.2009.01.008","article-title":"ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency","volume":"19","author":"Liang","year":"2009","journal-title":"Neuromuscul Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/8904_2013_236","article-title":"Fatty acid oxidation disorders in a Chinese population in Taiwan","volume":"11","author":"Chien","year":"2013","journal-title":"JIMD Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/0366-6999.222323","article-title":"Muscle magnetic resonance imaging for the differentiation of multiple acyl-CoA dehydrogenase deficiency and immune-mediated necrotizing myopathy","volume":"131","author":"Zhao","year":"2018","journal-title":"Chin Med J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/neup.12667","article-title":"Investigation of adult-onset multiple acyl-CoA dehydrogenase deficiency associated with peripheral neuropathy","volume":"40","author":"Huang","year":"2020","journal-title":"Neuropathology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1399-0004.2010.01421.x","article-title":"High frequency of ETFDH c","volume":"78","author":"Lan","year":"2010","journal-title":"Clin Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1432-1033.2003.03946.x","article-title":"Acyl-CoA dehydrogenases. A mechanistic overview","volume":"271","author":"Ghisla","year":"2004","journal-title":"Eur J Biochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/10409238.2021.1908952","article-title":"ETF dehydrogenase advances in molecular genetics and impact on treatment","volume":"56","author":"Missaglia","year":"2021","journal-title":"Crit Rev Biochem Mol Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jimd.12361","article-title":"CHIP control degradation of mutant ETF:QO through ubiquitylation in late-onset multiple acyl-CoA dehydrogenase deficiency","volume":"44","author":"Liu","year":"2021","journal-title":"J Inherit Metab Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/hmg\/dds175","article-title":"Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency","volume":"21","author":"Cornelius","year":"2012","journal-title":"Hum Mol Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6807-11-43","article-title":"Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif","volume":"11","author":"Er","year":"2011","journal-title":"BMC Struct Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ana.25338","article-title":"ETFDH mutations and flavin adenine dinucleotide homeostasis disturbance are essential for developing riboflavin-responsive multiple acyl-coenzyme A dehydrogenation deficiency","volume":"84","author":"Xu","year":"2018","journal-title":"Ann Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12944-018-0903-5","article-title":"Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency","volume":"17","author":"Missaglia","year":"2018","journal-title":"Lipids Health Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.ymgme.2013.10.007","article-title":"Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?","volume":"110","author":"Olsen","year":"2013","journal-title":"Mol Genet Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12881-020-00995-2","article-title":"A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family","volume":"21","author":"Ou","year":"2020","journal-title":"BMC Med Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12883-018-1221-2","article-title":"Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barre syndrome: two cases report","volume":"18","author":"Hong","year":"2018","journal-title":"BMC Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cca.2009.02.015","article-title":"Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency","volume":"404","author":"Law","year":"2009","journal-title":"Clin Chim Acta."},{"key":"B37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2362.2002.01045.x","article-title":"Molecular study of electron transfer flavoprotein alpha-subunit deficiency in two Japanese children with different phenotypes of glutaric acidemia type II","volume":"32","author":"Purevjav","year":"2002","journal-title":"Eur J Clin Invest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-014-0117-5","article-title":"Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency","volume":"9","author":"Grunert","year":"2014","journal-title":"Orphanet J Rare Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/brain\/122.12.2401","article-title":"Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies","volume":"122","author":"Vergani","year":"1999","journal-title":"Brain."},{"key":"B40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J Inherit Metab Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"E1976","DOI":"10.1002\/humu.21399","article-title":"Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B","volume":"32","author":"Ho","year":"2011","journal-title":"Hum Mutat."},{"key":"B42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10545-012-9513-y","article-title":"Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome","volume":"35","author":"Haack","year":"2012","journal-title":"J Inherit Metab Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMc1513610","article-title":"SLC25A32 mutations and riboflavin-responsive exercise intolerance","volume":"374","author":"Schiff","year":"2016","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.04.006","article-title":"Riboflavin-responsive and -non-responsive mutations in fad synthase cause multiple acyl-CoA dehydrogenase and combined respiratory-chain deficiency","volume":"98","author":"Olsen","year":"2016","journal-title":"Am J Hum Genet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.747360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T05:06:58Z","timestamp":1636348018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.747360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":44,"alternative-id":["10.3389\/fneur.2021.747360"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.747360","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"article-number":"747360"}}